Publication: Infectious hypodermal and hematopoietic necrosis virus-like particles encapsulating VP28 double-stranded RNA protect shrimp from white spot syndrome virus
Submitted Date
Received Date
Accepted Date
Issued Date
2019-04-15
Copyright Date
Announcement No.
Application No.
Patent No.
Valid Date
Resource Type
Edition
Resource Version
Language
File Type
No. of Pages/File Size
ISBN
ISSN
00448486
eISSN
Scopus ID
WOS ID
Pubmed ID
arXiv ID
Call No.
Other identifier(s)
2-s2.0-85061209180
Journal Title
Volume
Issue
item.page.oaire.edition
Start Page
End Page
Access Rights
Access Status
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Physical Location
Bibliographic Citation
Aquaculture. Vol.504, (2019), 260-266
Citation
Pitchanee Jariyapong, Charoonroj Chotwiwatthanakun, Chettupon Pooljun, Wattana Weerachatyanukul (2019). Infectious hypodermal and hematopoietic necrosis virus-like particles encapsulating VP28 double-stranded RNA protect shrimp from white spot syndrome virus. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/49776.
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Infectious hypodermal and hematopoietic necrosis virus-like particles encapsulating VP28 double-stranded RNA protect shrimp from white spot syndrome virus
Alternative Title(s)
Author's Affiliation
Author's E-mail
Editor(s)
Editor's Affiliation
Corresponding Author(s)
Creator(s)
Compiler
Advisor(s)
Illustrator(s)
Applicant(s)
Inventor(s)
Issuer
Assignee
Other Contributor(s)
Series
Has Part
Abstract
© 2019 Due to their host tissue specificity and unique physical properties that extend beyond that of other biological nano-containers, virus-like particles (VLPs) are gaining attention for their use as double-stranded RNA (dsRNA) nano-containers to control viral infections in shrimp aquaculture. In this study, we used a hypodermal and hematopoietic necrosis virus (IHHNV)-like particle to encapsulate VP28 dsRNA (VP28 dsRNA + IHHNV-VLPs) and tested it for its protection against white spot syndrome virus (WSSV). The tissue specificity of the VP28 dsRNA + IHHNV-VLPs was visualized by confocal microscopy, revealing that they were targeted to many shrimp tissues such as the thoracic muscles, gills, and connective tissues in the hepatopancreas. Interestingly, the administration of VP28 dsRNA + IHHNV-VLPs silenced the WSSV challenge better than the non-encapsulated (naked) VP28 dsRNA, which was evident by the lower VP28 gene and viral copy numbers in the tissues after the challenge. Administering VP28 dsRNA + IHHNV-VLPs also stimulated the up-regulation of many immune-related genes as early as 6 h post administration, particularly those involved in fighting WSSV infection. These dual actions of the VP28 dsRNA + IHHNV-VLPs reduced the shrimp cumulative mortality rate more than did the naked VP28 dsRNA. We therefore believe that IHHNV-VLPs can act both as nano-containers for therapeutic agents and as an immunostimulant that increases protection against WSSV infection for shrimp.